Here’s what you should know about him:
1. Mr. Thomas has more than 30 years of sales experience.
2. He will lead sales for the DiLumen EIP and DiLumen C2 platforms.
3. Mr. Thomas most recently worked at USGI Medical, where he was vice president of global sales and business development.
4. Lumendi CEO Peter Johann, PhD, said, “Mike’s experience with emerging technologies in medical device companies and his track record of delivering superior results domestically and globally will help us challenge and inspire our customers to think differently as we work to migrate many gastrointestinal surgeries to less invasive endolumenal procedures.”
More articles on gastroenterology:
How EHRs can help ASCs & anesthesia providers safely prescribe opioids — 6 takeaways
Yale New Haven Health opens musculoskeletal ASC — 3 facts
What providers should know about issuing advance notice of noncoverage — 8 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.